N-Nitroso-N-methylurea
Skeletal formula of N-nitroso-N-methylurea | |||
|
|||
Names | |||
---|---|---|---|
IUPAC name
1-Methyl-1-nitrosourea[1]
|
|||
Identifiers | |||
684-93-5 | |||
Abbreviations | NMU[citation needed] | ||
1756040 | |||
ChEBI | CHEBI:50102 | ||
ChEMBL | ChEMBL288958 | ||
ChemSpider | 12177 | ||
EC Number | 211-678-4 | ||
Jmol 3D model | Interactive image Interactive image |
||
KEGG | C14595 | ||
MeSH | Methylnitrosourea | ||
PubChem | 12699 | ||
|
|||
|
|||
Properties | |||
C2H5N3O2 | |||
Molar mass | 103.08 g·mol−1 | ||
log P | −0.302 | ||
Acidity (pKa) | 12.365 | ||
Basicity (pKb) | 1.632 | ||
Related compounds | |||
Related ureas
|
ENU | ||
Related compounds
|
|||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
verify (what is ?) | |||
Infobox references | |||
N-Nitroso-N-methylurea (NMU) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids, which can lead to AT:GC transition mutations.
NMU is the traditional precursor in the synthesis of diazomethane. However, because it is unstable at temperatures beyond 20 °C and somewhat shock-sensitive, it has become obsolete for this purpose and replaced by other N-nitroso compounds: (N-methyl)nitrosamides and nitrosamines. Most chemical supply houses have stopped carrying it.
Acute exposure to NMU in humans can result in skin and eye irritation, headache, nausea, and vomiting.[2] NMU is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals (IARC 1972, 1978, 1987).[3] Various cancers induced in animal models include: squamous cell carcinomas of the forestomach, sarcomas and gliomas of the brain, adenocarcinomas of the pancreas, mammary carcinomas, leukemia, and lymphomas.[3] However, the actual potential for human exposure is quite limited, as the chemical is not produced or used in large quantities [3]
NMU is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, fetal growth retardation, and increased fetal resorption.[4][5][6] Exposure to NMU during pre-implantation, post-implantation, organogenesis, or by paternal exposure can result in these effects.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Hazardous Substance Fact Sheet for NMU New Jersey Department of Health and Senior Services
- ↑ 3.0 3.1 3.2 NMU Substance Profile NTP, Report on Carcinogens, Eleventh Edition
- ↑ Wada, A., et al. (1994). Induction of Congenital Malformations in Mice by Paternal Methylnitrosourea Treatment. Congenital Anomalies 34:65-70.
- ↑ Nagao, T., et al. (1991). Induction of Fetal Malformations After Treatment of Mouse Embryos with Methylnitrosourea at the Preimplantation Stages. Teratogenesis, Carcinogenesis, and Mutagenesis 11:1-10.
- ↑ Faustman, E., et al. (1989). In Vitro Developmental Toxicity of Five Direct-Acting Alkylating Agents in Rodent Embryos: Structure-Activity Patterns. Teratology 40:199-210.
- Pages with broken file links
- Articles without UNII source
- Articles with unsourced statements from May 2012
- Articles with changed InChI identifier
- Pages using collapsible list with both background and text-align in titlestyle
- Carcinogens
- Nitrosamines
- Ureas
- Nitrosoureas
- IARC Group 2A carcinogens
- Mutagens
- Teratogens
- Embryotoxicants
- Male-mediated teratogens